Tübingen, Baden-Württemberg
We are currently seeking a
to support our R&D team to develop innovative product candidates for cancer immunotherapy.
You will work in an interdisciplinary environment with colleagues from research and clinical departments at our site in Tuebingen (Germany) and will contribute to our mission of developing new cancer immunotherapies to improve clinical outcomes for patients. Tuebingen is a vibrant University city close to Stuttgart in the south of Germany. This is a permanent position.
You will support Immatics’ efforts to further digitalize the management of clinical data for cancer immunotherapies. Your main responsibilities will include but are not limited to the following tasks:
We kindly ask you to enclose with your application your transcripts of records (including all courses attended and grades earned) for all degrees (i.e., Bachelor, Master, PhD, if applicable) and to briefly mention which of your professional skills are relevant for this position from your point of view as well as why you are interested in working at Immatics.
We are a committed and inspired team and cherish the collegial, highly motivated, and family-friendly atmosphere within Immatics. Our culture allows for a high level of originality, independent thinking, and initiative. We believe in supporting our employees’ professional and social skills: We enable them to join conferences and trainings as well as to enjoy our Immatics benefits - e.g., job bike, job ticket, Health Programs, childcare benefits, relocation allowance, Company summer and winter events.
*We value diversity and inclusion. Immatics N.V. and all Immatics subsidiaries are equal opportunity employers that evaluate qualified applicants without regard to race, color, national origin, religion, gender, age, marital status, disability, veteran status, personal orientation, gender identity, or other characteristics protected by law.
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry. Operating from Tuebingen, Munich and Houston, we are committed to delivering the power of T cells and to unlocking new avenues for patients in their fight against cancer. For more detailed information, visit www.immatics.com.
Paul-Ehrlich-Str. 15
72076 Tübingen
Baden-Württemberg
Deutschland